Studies in Management and Finance, Harvard Business School; PhD, University of Antwerp. Formerly: with Sanofi, Sterling Winthrop and Nycomed-Amersham in a variety of R&D management positions in Europe and the US; Global CEO, Solvay Pharmaceuticals, until it was acquired by Abbott Laboratories. Former President, Belgian Chamber of Commerce for Russia. Currently, President and CEO, Selecta Biosciences, Boston and Moscow. Former Director: Innogenetics, Gent, Belgium; Arqule, Woburn, MA, US. Currently, Director, Galapagos, Mechelen, Belgium.